183 related articles for article (PubMed ID: 21920020)
1. Nondepleting anti-CD40-based therapy prolongs allograft survival in nonhuman primates.
Badell IR; Thompson PW; Turner AP; Russell MC; Avila JG; Cano JA; Robertson JM; Leopardi FV; Strobert EA; Iwakoshi NN; Reimann KA; Ford ML; Kirk AD; Larsen CP
Am J Transplant; 2012 Jan; 12(1):126-35. PubMed ID: 21920020
[TBL] [Abstract][Full Text] [Related]
2. A novel, blocking, Fc-silent anti-CD40 monoclonal antibody prolongs nonhuman primate renal allograft survival in the absence of B cell depletion.
Cordoba F; Wieczorek G; Audet M; Roth L; Schneider MA; Kunkler A; Stuber N; Erard M; Ceci M; Baumgartner R; Apolloni R; Cattini A; Robert G; Ristig D; Munz J; Haeberli L; Grau R; Sickert D; Heusser C; Espie P; Bruns C; Patel D; Rush JS
Am J Transplant; 2015 Nov; 15(11):2825-36. PubMed ID: 26139432
[TBL] [Abstract][Full Text] [Related]
3. CD40 blockade combines with CTLA4Ig and sirolimus to produce mixed chimerism in an MHC-defined rhesus macaque transplant model.
Page A; Srinivasan S; Singh K; Russell M; Hamby K; Deane T; Sen S; Stempora L; Leopardi F; Price AA; Strobert E; Reimann KA; Kirk AD; Larsen CP; Kean LS
Am J Transplant; 2012 Jan; 12(1):115-25. PubMed ID: 21929643
[TBL] [Abstract][Full Text] [Related]
4. CTLA4Ig prevents alloantibody formation following nonhuman primate islet transplantation using the CD40-specific antibody 3A8.
Badell IR; Russell MC; Cardona K; Shaffer VO; Turner AP; Avila JG; Cano JA; Leopardi FV; Song M; Strobert EA; Ford ML; Pearson TC; Kirk AD; Larsen CP
Am J Transplant; 2012 Jul; 12(7):1918-23. PubMed ID: 22458552
[TBL] [Abstract][Full Text] [Related]
5. CD40-specific costimulation blockade enhances neonatal porcine islet survival in nonhuman primates.
Thompson P; Cardona K; Russell M; Badell IR; Shaffer V; Korbutt G; Rayat GR; Cano J; Song M; Jiang W; Strobert E; Rajotte R; Pearson T; Kirk AD; Larsen CP
Am J Transplant; 2011 May; 11(5):947-57. PubMed ID: 21521467
[TBL] [Abstract][Full Text] [Related]
6. A novel monoclonal antibody to CD40 prolongs islet allograft survival.
Lowe M; Badell IR; Thompson P; Martin B; Leopardi F; Strobert E; Price AA; Abdulkerim HS; Wang R; Iwakoshi NN; Adams AB; Kirk AD; Larsen CP; Reimann KA
Am J Transplant; 2012 Aug; 12(8):2079-87. PubMed ID: 22845909
[TBL] [Abstract][Full Text] [Related]
7. Prolonged islet graft survival in NOD mice by blockade of the CD40-CD154 pathway of T-cell costimulation.
Molano RD; Berney T; Li H; Cattan P; Pileggi A; Vizzardelli C; Kenyon NS; Ricordi C; Burkly LC; Inverardi L
Diabetes; 2001 Feb; 50(2):270-6. PubMed ID: 11272136
[TBL] [Abstract][Full Text] [Related]
8. Blockade of CD40-CD154 at the time of donor-specific blood transfusion does not lead to prolonged kidney allograft survival in nonhuman primates.
Ringers J; Haanstra KG; Kroczek RA; Kliem K; Kuhn EM; Wubben J; Ossevoort MA; Volk HD; Jonker M
Transplantation; 2002 Mar; 73(6):862-6. PubMed ID: 11923684
[TBL] [Abstract][Full Text] [Related]
9. Long-term hepatic allograft acceptance based on CD40 blockade by ASKP1240 in nonhuman primates.
Oura T; Yamashita K; Suzuki T; Fukumori D; Watanabe M; Hirokata G; Wakayama K; Taniguchi M; Shimamura T; Miura T; Okimura K; Maeta K; Haga H; Kubota K; Shimizu A; Sakai F; Furukawa H; Todo S
Am J Transplant; 2012 Jul; 12(7):1740-54. PubMed ID: 22420525
[TBL] [Abstract][Full Text] [Related]
10. Alternative immunomodulatory strategies for xenotransplantation: CD40/154 pathway-sparing regimens promote xenograft survival.
Thompson P; Badell IR; Lowe M; Turner A; Cano J; Avila J; Azimzadeh A; Cheng X; Pierson RN; Johnson B; Robertson J; Song M; Leopardi F; Strobert E; Korbutt G; Rayat G; Rajotte R; Larsen CP; Kirk AD
Am J Transplant; 2012 Jul; 12(7):1765-75. PubMed ID: 22458586
[TBL] [Abstract][Full Text] [Related]
11. Treatment of allograft recipients with donor-specific transfusion and anti-CD154 antibody leads to deletion of alloreactive CD8+ T cells and prolonged graft survival in a CTLA4-dependent manner.
Iwakoshi NN; Mordes JP; Markees TG; Phillips NE; Rossini AA; Greiner DL
J Immunol; 2000 Jan; 164(1):512-21. PubMed ID: 10605049
[TBL] [Abstract][Full Text] [Related]
12. Fc-Silent Anti-CD154 Domain Antibody Effectively Prevents Nonhuman Primate Renal Allograft Rejection.
Kim SC; Wakwe W; Higginbotham LB; Mathews DV; Breeden CP; Stephenson AC; Jenkins J; Strobert E; Price K; Price L; Kuhn R; Wang H; Yamniuk A; Suchard S; Farris AB; Pearson TC; Larsen CP; Ford ML; Suri A; Nadler S; Adams AB
Am J Transplant; 2017 May; 17(5):1182-1192. PubMed ID: 28097811
[TBL] [Abstract][Full Text] [Related]
13. A human anti-CD40 monoclonal antibody, 4D11, for kidney transplantation in cynomolgus monkeys: induction and maintenance therapy.
Aoyagi T; Yamashita K; Suzuki T; Uno M; Goto R; Taniguchi M; Shimamura T; Takahashi N; Miura T; Okimura K; Itoh T; Shimizu A; Furukawa H; Todo S
Am J Transplant; 2009 Aug; 9(8):1732-41. PubMed ID: 19519810
[TBL] [Abstract][Full Text] [Related]
14. Role of anti-CD40 antibody-mediated costimulation blockade on non-Gal antibody production and heterotopic cardiac xenograft survival in a GTKO.hCD46Tg pig-to-baboon model.
Mohiuddin MM; Singh AK; Corcoran PC; Hoyt RF; Thomas ML; Lewis BG; Eckhaus M; Dabkowski NL; Belli AJ; Reimann KA; Ayares D; Horvath KA
Xenotransplantation; 2014; 21(1):35-45. PubMed ID: 24164510
[TBL] [Abstract][Full Text] [Related]
15. Development of a chimeric anti-CD40 monoclonal antibody that synergizes with LEA29Y to prolong islet allograft survival.
Adams AB; Shirasugi N; Jones TR; Durham MM; Strobert EA; Cowan S; Rees P; Hendrix R; Price K; Kenyon NS; Hagerty D; Townsend R; Hollenbaugh D; Pearson TC; Larsen CP
J Immunol; 2005 Jan; 174(1):542-50. PubMed ID: 15611281
[TBL] [Abstract][Full Text] [Related]
16. Anti-CD40 therapy extends renal allograft survival in rhesus macaques.
Pearson TC; Trambley J; Odom K; Anderson DC; Cowan S; Bray R; Lin A; Hollenbaugh D; Aruffo A; Siadak AW; Strobert E; Hennigar R; Larsen CP
Transplantation; 2002 Oct; 74(7):933-40. PubMed ID: 12394833
[TBL] [Abstract][Full Text] [Related]
17. Islet allograft rejection in nonobese diabetic mice involves the common gamma-chain and CD28/CD154-dependent and -independent mechanisms.
Demirci G; Strom TB; Li XC
J Immunol; 2003 Oct; 171(7):3878-85. PubMed ID: 14500690
[TBL] [Abstract][Full Text] [Related]
18. ASKP1240, a fully human anti-CD40 monoclonal antibody, prolongs pancreatic islet allograft survival in nonhuman primates.
Watanabe M; Yamashita K; Suzuki T; Kamachi H; Kuraya D; Koshizuka Y; Ogura M; Yoshida T; Aoyagi T; Fukumori D; Shimamura T; Okimura K; Maeta K; Miura T; Sakai F; Todo S
Am J Transplant; 2013 Aug; 13(8):1976-88. PubMed ID: 23841873
[TBL] [Abstract][Full Text] [Related]
19. Pre-clinical results in pig-to-non-human primate islet xenotransplantation using anti-CD40 antibody (2C10R4)-based immunosuppression.
Shin JS; Kim JM; Min BH; Yoon IH; Kim HJ; Kim JS; Kim YH; Kang SJ; Kim J; Kang HJ; Lim DG; Hwang ES; Ha J; Kim SJ; Park WB; Park CG
Xenotransplantation; 2018 Jan; 25(1):. PubMed ID: 29057561
[TBL] [Abstract][Full Text] [Related]
20. Blockade of CD40-mediated signaling is sufficient for inducing islet but not skin transplantation tolerance.
Phillips NE; Markees TG; Mordes JP; Greiner DL; Rossini AA
J Immunol; 2003 Mar; 170(6):3015-23. PubMed ID: 12626555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
